Anita Dushyanth

Stock Analyst at Berenberg

(2.58)
# 2,144
Out of 5,146 analysts
4
Total ratings
75%
Success rate
15.74%
Average return

Stocks Rated by Anita Dushyanth

UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $20.75
Upside: -3.61%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $2.25
Upside: +477.78%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.64
Upside: +73,070.73%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $23.41
Upside: +297.27%